Lv5
968 积分 2023-09-13 加入
Phase 2 pilot trial of tislelizumab plus low-dose nab-paclitaxel for extensive very high-risk non-muscle-invasive bladder cancer
1个月前
已完结
Adjuvant immunotherapy in high-risk muscle-invasive urothelial cancer: an updated meta-analysis of randomized controlled trials
2个月前
已完结
Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)
2个月前
已完结
Long‐term outcomes and cost savings of office fulguration of papillary Ta low‐grade bladder cancer
2个月前
已完结
A Systematic Review of the Efficacy and Safety of Outpatient Bladder Tumour Ablation
2个月前
已完结
Impact of BMI Category on Recurrence and Progression of Non-Muscle Invasive Bladder Cancer Prognosis
2个月前
已完结
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial
2个月前
已完结
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)
2个月前
已完结
脐尿管癌诊断与治疗的研究进展
2个月前
已完结
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926
2个月前
已完结
皖公网安备34019202002308
